Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis

• Main Authors: Sollip Kim (Author), Hyun-Jung Kim (Author), Hyeong-Sik Ahn (Author), Se Won Oh (Author), Kum Hyun Han (Author), Tae-Hyun Um (Author), Chong-Rae Cho (Author), Sang Youb Han (Author)
• Format: Book
• Published: The Korean Society of Nephrology, 2017-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Hyperuricemia is reported to be related to rapid progression of renal function in patients with chronic kidney disease (CKD). Allopurinol, a uric acid lowering agent, protects renal progression. However, it is not widely used in patients with CKD because of its serious adverse event. Feb...